Jocelyn Johnson, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 188 County Road 133, Bono, AR 72416 Phone: 870-919-3141 Fax: 870-931-6599 |
Kenzley Malone Wilson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 948 County Road 113, Bono, AR 72416 Phone: 870-219-5534 Fax: 870-203-9335 |
Mr. Zachary Tyler Norman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3898 County Road 318, Bono, AR 72416 Phone: 870-219-0829 Fax: 870-932-1155 |
News Archive
Additional investment in the world's 1.2 billion adolescents - 88 percent of whom live in the developing world - has the potential to help alleviate inequality and poverty, UNICEF said in its annual State of the World's Children report released on Friday, IRIN reports.
Researchers at Karolinska Institutet in Sweden have found an explanation for why the level of kynurenic acid (KYNA) is higher in the brains of people with schizophrenia or bipolar disease with psychosis. The study, which is published in the scientific periodical Molecular Psychiatry, identifies a gene variant associated with an increased production of KYNA.
At the 61st ASMS Conference on Mass Spectrometry and Allied Topics, Bruker today announced mass spectrometry-based product introductions for life-science and clinical research, for biotech/pharma/CRO customers, as well as for industrial and applied markets. The new mass spectrometry systems and solutions are designed to deliver confident analyses with dramatically enhanced resolution, sensitivity and precision.
GlaxoSmithKline (GSK) and Imperial College London today announce a unique research collaboration in medical imaging. GSK will contribute funding of £28m for the construction of a new Clinical Imaging Centre, next to Hammersmith Hospital in West London, UK. Research will focus on cancer, stroke, neurological diseases such as Parkinson's and multiple sclerosis and psychiatric diseases. In association with the Clinical Imaging Centre, GSK and Imperial have entered into a 10-year research agreement for medical imaging.
A molecular technique originally developed at the University of North Carolina at Chapel Hill has taken one step closer to becoming a treatment for the devastating genetic disease Duchenne muscular dystrophy.
› Verified 4 days ago